First report from a single center retrospective study in Kazakhstan on ...
Acute myeloid leukemia (AML) is the most common hematological malignancy in adults. In the last decade, internationally approved AML treatment guidelines, including hematopoietic stem cell transplantation are widely used in Kazakhstan. The categorization of acute myeloid leukemia was done according to the French-American British classification.
This study gives an overview of the first 10-year experience's results, implementation of acute myeloid leukemia treatment guidelines in Kazakhstan. The main limitation is a bias by age: the ...
PDF First report from a single center retrospective study in ...
This study gives an overview of the first 10-year experience's results, implementation of acute myeloid leukemia treatment guidelines in Kazakhstan. The main limitation is a bias by age: the ...
Acute myeloid (myelogenous) leukemia (AML) treatment options include chemotherapy, radiation therapy, stem cell transplant, and other medications. Cytogenetic analysis helps predict treatment outcomes . Get detailed information about AML in this summary for clinicians.
Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia ...
We evaluated 10-year longitudinal data from patients with AML treated in real-world clinical practice at community and academic institutions to understand the evolution of diagnosis and treatment of patients with this myeloid condition.
Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments . Diagnosis, risk assessment, monitoring, and therapeutic management of AML have changed dramatically in the last decade due to increased ...
Overview of Acute Myeloid Leukemia Treatment Outcomes First Report
For patients with acute myeloid leukemia (AML) who are 75 years of age or older or who are ineligible for intensive induction chemotherapy, azacitidine or decitabine plus venetoclax is the standard...
Treatment options for adult acute myeloid leukemia (AML) include chemotherapy, radiation therapy, stem cell transplant, and other medications. Get detailed information about the treatment of new and recurrent AML in this expert-reviewed summary.
Clinical Outcomes of Patients With Newly Diagnosed Acute Myeloid ...
We analyzed retrospectively a cohort of 192 patients with newly diagnosed acute myeloid leukemia (AML) treated between 2005 and 2019 in a large County Hospital System.
This study aims to characterize first -line (1L) and second-line (2L) treatment patterns and outcomes in newly diagnosed (ND) and relapsed/refractory (R/R) AML patients, in the context of these newly available therapies.